A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
NCT05320146
·
clinicaltrials.gov ↗
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Nonalcoholic Steatohepatitis (NASH)
Interventions
OTHER:
MRI-PDFF
Sponsor
Corcept Therapeutics